Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer

Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) cells do not contain various receptors for targeted treatment, a reason behind the poor prognosis of this disease. In this study, biocompatible theranostic erythrocyte-derived nanoparticles (EDNs) were developed and evaluated for effective early diagnosis and tre...

Full description

Bibliographic Details
Main Authors: Moon Jung Choi, Yeon Kyung Lee, Kang Chan Choi, Do Hyun Lee, Hwa Yeon Jeong, Seong Jae Kang, Min Woo Kim, Young Myoung You, Chan Su Im, Tae Sup Lee, Yong Serk Park
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceutics
Subjects:
erythrocyte-derived nanoparticle
drug delivery system
triple-negative breast cancer
tumor-targeted therapy
quantum dots
Online Access:https://www.mdpi.com/1999-4923/15/2/350

Internet

https://www.mdpi.com/1999-4923/15/2/350

Similar Items